Contact Us   |   Sign In   |   Register
Resources - National
Share |

National Resources

National Organizations

American Pharmacists Association (APhA)

     - Toolkit for Pharmacists Month

National Alliance of State Pharmacy Associations (NASPA)

National Community Pharmacists Association (NCPA)

National Association of Chain Drug Stores (NACDS)


NCPA 2016 Awards Nomination Forms

NCPA 2016 Willard B. Simmons Independent Pharmacist of the Year 

NCPA 2016 Prescription Drug Safety Award


General Chapter <797> Revisions 2015

General Chapter <800>

NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014


Aetna Medicare Part D 2015 issues

How to assist beneficiaries who are affected

Temporary Processing Fix


Ebola Outbreak 2014

KDPH Provider Hotline information


Contact Information:

Phone: 502-564-5461



8:00 AM - 4:30 PM ET Monday - Friday

After hours, 888-9REPORT continues to be used by clinicians for reporting potential cases of Ebola




Resources from RxResponse

Procedural Guidance on the Proper Packaging of Ebola Suspected Waste

Guidelines for the Initial Management of Patients in Emergency Departments with Suspected Ebola Virus Disease

Ebola FAQs

Ebola Detection Card

Ebola Screening for Healthcare Providers

Ebola Screening for EMS


FDA Issues some Emergency Use Authorizations for Ebola Tests

The FDA has issued emergency use authorizations for new tests that allow hospitals with the right equipment to screen symptomatic patients' blood and urine samples for Ebola and receive results in about an hour.   Click here for more.


Rapid Ebola Test available for hospitals

Click here for more.

USP’s proposed new General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings

Letter from national organizations 7.10.2014

Pharmacist Lawmakers

Pharmacists in state office June 2014

2015 CMS Proposed Rule

Click here for information on the Part D Plan.
Click here for information on the Medicare Advantage Capitation Rates
Click here for Tavenner's letter to Congress

Joint letter to HHS regarding rescheduling hydrocodone products

2013 DuoDote FDA Extension

CPE Monitor

2013 National Poverty Guidelines

USP Prescription Container Labeling Standard

Changes to HIPAA Requirements September 2013

RxAlly's closure notice August 2013

Health Care Reform Information

Health Insurance Exchange

10 Things Providers Need to Know

10 Things to Tell Your Patients

Protect Yourself from Fraud in Health Insurance Marketplace

Things to Think About When Choosing a Plan

Information on S. 959 (Compounding Bill)

Compounding Pedigree Bill Before Congress information sheet

Grassroots Alert

Compounding Hearings May 2013

Dr. Janet Woodcock , Director, Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services, Silver Spring, MD

Carmen S. Catizone , Executive Director, National Association of Boards of Pharmacy, Mount Prospect, IL

Allan Coukell , Director, Medical Programs, The Pew Charitable Trusts, Washington, DC

David G. Miller , Executive Vice President and CEO, International Academy of Compounding Pharmacy, Missouri City, TX

Dr. Kasey K. Thompson , Vice President, Office of Policy, Planning and Communications, American Society of Health-System Pharmacists, Bethesda, MD

Dinner Invitation from Noven

Membership Software Powered by YourMembership  ::  Legal